PATENT CLAIM ANALYSIS

Application Number: 15763095
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):

Claim (Index 4):
The compound of  claim 3 , wherein R 3  is selected from the group consisting of: Y is C(\u2550O); OC(\u2550O), NHC(\u2550O), S\u2550O, S(\u2550O) 2 , or NHS(\u2550O) 2 ; R 6 , R 7 , R are each independently hydrogen, halogen, CN, C 1-4  alkyl, C 1-6  alkoxyalkyl, C 1-8  alkylaminoalkyl, or C 1-4  alkylphenyl; or R 7  and R 8  taken together form a bond.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13805471', '13780557', '15530681', '14376307', '15410716']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8439391213787905
- 35 USC 102 Novelty (BERT): 0.537824561140466
- Combined Prediction Score: 0.813327665354958
- Mean Citation Score: 394.870806
- Max Citation Score: 395.57306
- Similarity Product: 262.67035744347214

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test